These clinical findings indicate that targeting the P2X7 receptor alone is inadequate to suppress the deleterious effect of pro-inflammatory cytokines that might be released by other signalling pathways in rheumatoid arthritis. Here, P2RX7 is linked to rheumatoid arthritis.